Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on May 18, 2020, reporting events occurring on May 13, 2020. The registrant is an emerging growth company incorporated in California. Note: The request metadata references "Vivani Medical, Inc.," but the filing text explicitly identifies the registrant as Second Sight Medical Products, Inc.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed is a specific compensatory payment.
- Compensatory Payment: A one-time cash bonus of $100,000 awarded to John T. Blake, Chief Financial Officer.
Material Changes
The material change reported is the execution of Amendment No. 1 to the Executive Employment Agreement with John T. Blake, dated March 21, 2018. Under this amendment:
- Mr. Blake receives a $100,000 cash bonus for services rendered.
- In the event of termination without cause, Mr. Blake's separation amounts will be reduced by the $100,000 bonus amount.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies beyond the specific terms of the employment amendment. No unusual items or financial restatements were reported.
Investor Verification Checklist
- Verify the identity of the registrant (Second Sight Medical Products, Inc.) versus the metadata reference (Vivani Medical, Inc.).
- Review the full text of Amendment No. 1 (Exhibit 10.1) to understand the specific conditions for the bonus and the calculation of potential separation payments.
- Confirm the impact of the $100,000 bonus on the company's immediate cash position and future compensation liabilities.